When did Nature's Sunshine Products report Q4 2024 earnings?

Nature's Sunshine Products (NATR) reported Q4 2024 earnings on March 11, 2025 after market close.

What were Nature's Sunshine Products's Q4 2024 revenue and EPS?

Nature's Sunshine Products reported revenue of $118.2M and eps of $-0.02 for Q4 2024.

Did Nature's Sunshine Products beat estimates in Q4 2024?

Revenue beat the consensus estimate of $109.3M by $8.9M. EPS missed the consensus estimate of $0.20 by $0.22.

Where can I find Nature's Sunshine Products's Q4 2024 SEC filings?

You can read the 10-K periodic report (0001628280-25-012082) directly on SEC EDGAR. The filing index links above go to sec.gov.

Nature's Sunshine Products NATR Q4 2024 Annual earnings

Reported March 11, 2025 · After market close

Revenue$118.2MBeat by $8.9M

EPS-$0.02Miss by $0.22

Revenue estimate$109.3M

EPS estimate$0.20

Next report

Aug 6, 2026 (In 1 week)

Revenue estimate$123.7M

EPS estimate$0.27

Financials

Q4 2024

Income statement

See full

Revenue$118.2M+8.5%

Gross profit$85.1M+8.6%

Operating income$4.6M-20.3%

Net income--100%

EPS (diluted)$0.00-100%

Balance sheet

See full

Cash & equivalents$84.7M+2.8%

Total debt$14.2M-4.8%

Total equity$161.0M+0.9%

Total assets$240.9M-3.6%

Cash flow

See full

Operating cash flow$12.2M+26.9%

CapEx$2.2M+75.9%

Free cash flow$10.0M+19.6%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$270.85M-17.5%

Enterprise value$200.36M-23.2%

P/E33.8×+12.0×

P/S0.6×-0.1×

Profitability

See full

Gross margin71.5%-0.7pp

Operating margin4.4%+0.2pp

Net margin1.8%-1.6pp

FCF margin3.2%-3.8pp

Returns & leverage

See full

Return on equity5%-4.8pp

Debt / equity0.1×0.0×

Current ratio2.4×+0.3×

Segments

By product

See full

General health$46.1M-1.2%

Digestive$34.6M+54.3%

Cardiovascular$19.1M-2.1%

Immunity$12.5M+38.3%

Personal care$5.6M+22.5%

By segment

See full

Asia$56.3M+17.7%

North America$35.1M-1.6%

Europe$21.3M+8.3%

Latin America and Other$5.5M-4.8%

By geography

See full

United States$32.3M—

Taiwan$20.1M—

South Korea$12.4M—

Japan$11.8M—

Versus estimates

Revenue

Q1 2026$122.9MBeat by $742.0K Q4 2025$123.8MBeat by $2.3M Q3 2025$128.3MBeat by $6.7M Q2 2025$114.8MMiss by $4.6M Q1 2025$113.2MMiss by $1.2M

Q4 2024$118.2MBeat by $8.9M

Diluted EPS

Q1 2026$0.30Beat by $0.10 Q4 2025$0.30Beat by $0.11 Q3 2025$0.36Beat by $0.17 Q2 2025$0.35Beat by $0.17 Q1 2025$0.25Beat by $0.08

Q4 2024-$0.02Miss by $0.22

Ask the moment Nature's Sunshine Products reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Nature's Sunshine Products report Q4 2024 earnings?: Nature's Sunshine Products (NATR) reported Q4 2024 earnings on March 11, 2025 after market close.
What were Nature's Sunshine Products's Q4 2024 revenue and EPS?: Nature's Sunshine Products reported revenue of $118.2M and eps of $-0.02 for Q4 2024.
Did Nature's Sunshine Products beat estimates in Q4 2024?: Revenue beat the consensus estimate of $109.3M by $8.9M. EPS missed the consensus estimate of $0.20 by $0.22.
Where can I find Nature's Sunshine Products's Q4 2024 SEC filings?: You can read the 10-K periodic report (0001628280-25-012082) directly on SEC EDGAR. The filing index links above go to sec.gov.